ARTICLE | Company News
DyoDelta Biosciences Ltd., University of Patras deal
March 25, 2002 8:00 AM UTC
DyoDelta received an exclusive license to the university’s DDB-202 myelin basic protein (MBP) epitope analog to treat multiple sclerosis (MS). The company said MBP is an autoantigen involved in MS. ...